Greater depressive symptoms, cognition, and markers of brain aging

Northern Manhattan Study

Adina Zeki Al Hazzouri, Michelle R. Caunca, Juan Carlos Nobrega, Tali Elfassy, Ying Kuen Cheung, Noam Alperin, Chuanhui Dong, Mitchell S.V. Elkind, Ralph L Sacco, Charles DeCarli, Clinton B. Wright

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: We examined whether greater depressive symptoms were associated with domain-specific cognitive performance, change in cognition, and MRI markers of brain atrophy and subclinical cerebrovascular disease in a diverse sample of older adults from the Northern Manhattan Study. METHODS: Data were analyzed from the Northern Manhattan Study, a prospective cohort study of mostly Caribbean Hispanic, stroke-free, older adults. A total of 1,111 participants had baseline measures of depressive symptoms, measured as the Center of Epidemiological Studies-Depression Scale, MRI markers, and cognitive function. A Center of Epidemiological Studies-Depression score ≥16 was considered indicative of greater depressive symptoms. Multivariable linear and logistic regression models were used to examine the associations of interest. RESULTS: At baseline, 22% of participants had greater depressive symptoms. Greater depressive symptoms were significantly associated with worse baseline episodic memory in models adjusted for sociodemographic, vascular risk factor, behavioral, and antidepressive medication variables (β [95% confidence interval] = -0.21 [-0.33 to -0.10], p = 0.0003). Greater depressive symptoms were also associated with smaller cerebral parenchymal fraction (β [95% confidence interval] = -0.56 [-1.05 to -0.07], p = 0.02) and increased odds of subclinical brain infarcts (odds ratio [95% confidence interval] = 1.55 [1.00-2.42], p = 0.05), after adjustment for sociodemographic, behavioral, and vascular risk factor variables. Greater depressive symptoms were not significantly associated with white matter hyperintensity volume, hippocampal volume, or change in cognition over an average of 5 years. Results were unchanged when stabilized inverse probability weights were applied to address selective attrition during the study period. CONCLUSIONS: In this sample of mostly Caribbean Hispanic, stroke-free, older adults, greater depressive symptoms were associated with worse episodic memory, smaller cerebral volume, and silent infarcts.

Original languageEnglish (US)
Pages (from-to)e2077-e2085
JournalNeurology
Volume90
Issue number23
DOIs
StatePublished - Jun 5 2018

Fingerprint

Cognition
Depression
Brain
Episodic Memory
Confidence Intervals
Hispanic Americans
Epidemiologic Studies
Logistic Models
Stroke
Cerebrovascular Disorders
Atrophy
Linear Models
Cohort Studies
Odds Ratio
Prospective Studies
Weights and Measures

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Greater depressive symptoms, cognition, and markers of brain aging : Northern Manhattan Study. / Zeki Al Hazzouri, Adina; Caunca, Michelle R.; Nobrega, Juan Carlos; Elfassy, Tali; Cheung, Ying Kuen; Alperin, Noam; Dong, Chuanhui; Elkind, Mitchell S.V.; Sacco, Ralph L; DeCarli, Charles; Wright, Clinton B.

In: Neurology, Vol. 90, No. 23, 05.06.2018, p. e2077-e2085.

Research output: Contribution to journalArticle

Zeki Al Hazzouri, A, Caunca, MR, Nobrega, JC, Elfassy, T, Cheung, YK, Alperin, N, Dong, C, Elkind, MSV, Sacco, RL, DeCarli, C & Wright, CB 2018, 'Greater depressive symptoms, cognition, and markers of brain aging: Northern Manhattan Study', Neurology, vol. 90, no. 23, pp. e2077-e2085. https://doi.org/10.1212/WNL.0000000000005639
Zeki Al Hazzouri, Adina ; Caunca, Michelle R. ; Nobrega, Juan Carlos ; Elfassy, Tali ; Cheung, Ying Kuen ; Alperin, Noam ; Dong, Chuanhui ; Elkind, Mitchell S.V. ; Sacco, Ralph L ; DeCarli, Charles ; Wright, Clinton B. / Greater depressive symptoms, cognition, and markers of brain aging : Northern Manhattan Study. In: Neurology. 2018 ; Vol. 90, No. 23. pp. e2077-e2085.
@article{25f0b1b1927f401ca66570e8aa5de9a2,
title = "Greater depressive symptoms, cognition, and markers of brain aging: Northern Manhattan Study",
abstract = "OBJECTIVE: We examined whether greater depressive symptoms were associated with domain-specific cognitive performance, change in cognition, and MRI markers of brain atrophy and subclinical cerebrovascular disease in a diverse sample of older adults from the Northern Manhattan Study. METHODS: Data were analyzed from the Northern Manhattan Study, a prospective cohort study of mostly Caribbean Hispanic, stroke-free, older adults. A total of 1,111 participants had baseline measures of depressive symptoms, measured as the Center of Epidemiological Studies-Depression Scale, MRI markers, and cognitive function. A Center of Epidemiological Studies-Depression score ≥16 was considered indicative of greater depressive symptoms. Multivariable linear and logistic regression models were used to examine the associations of interest. RESULTS: At baseline, 22{\%} of participants had greater depressive symptoms. Greater depressive symptoms were significantly associated with worse baseline episodic memory in models adjusted for sociodemographic, vascular risk factor, behavioral, and antidepressive medication variables (β [95{\%} confidence interval] = -0.21 [-0.33 to -0.10], p = 0.0003). Greater depressive symptoms were also associated with smaller cerebral parenchymal fraction (β [95{\%} confidence interval] = -0.56 [-1.05 to -0.07], p = 0.02) and increased odds of subclinical brain infarcts (odds ratio [95{\%} confidence interval] = 1.55 [1.00-2.42], p = 0.05), after adjustment for sociodemographic, behavioral, and vascular risk factor variables. Greater depressive symptoms were not significantly associated with white matter hyperintensity volume, hippocampal volume, or change in cognition over an average of 5 years. Results were unchanged when stabilized inverse probability weights were applied to address selective attrition during the study period. CONCLUSIONS: In this sample of mostly Caribbean Hispanic, stroke-free, older adults, greater depressive symptoms were associated with worse episodic memory, smaller cerebral volume, and silent infarcts.",
author = "{Zeki Al Hazzouri}, Adina and Caunca, {Michelle R.} and Nobrega, {Juan Carlos} and Tali Elfassy and Cheung, {Ying Kuen} and Noam Alperin and Chuanhui Dong and Elkind, {Mitchell S.V.} and Sacco, {Ralph L} and Charles DeCarli and Wright, {Clinton B.}",
year = "2018",
month = "6",
day = "5",
doi = "10.1212/WNL.0000000000005639",
language = "English (US)",
volume = "90",
pages = "e2077--e2085",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "23",

}

TY - JOUR

T1 - Greater depressive symptoms, cognition, and markers of brain aging

T2 - Northern Manhattan Study

AU - Zeki Al Hazzouri, Adina

AU - Caunca, Michelle R.

AU - Nobrega, Juan Carlos

AU - Elfassy, Tali

AU - Cheung, Ying Kuen

AU - Alperin, Noam

AU - Dong, Chuanhui

AU - Elkind, Mitchell S.V.

AU - Sacco, Ralph L

AU - DeCarli, Charles

AU - Wright, Clinton B.

PY - 2018/6/5

Y1 - 2018/6/5

N2 - OBJECTIVE: We examined whether greater depressive symptoms were associated with domain-specific cognitive performance, change in cognition, and MRI markers of brain atrophy and subclinical cerebrovascular disease in a diverse sample of older adults from the Northern Manhattan Study. METHODS: Data were analyzed from the Northern Manhattan Study, a prospective cohort study of mostly Caribbean Hispanic, stroke-free, older adults. A total of 1,111 participants had baseline measures of depressive symptoms, measured as the Center of Epidemiological Studies-Depression Scale, MRI markers, and cognitive function. A Center of Epidemiological Studies-Depression score ≥16 was considered indicative of greater depressive symptoms. Multivariable linear and logistic regression models were used to examine the associations of interest. RESULTS: At baseline, 22% of participants had greater depressive symptoms. Greater depressive symptoms were significantly associated with worse baseline episodic memory in models adjusted for sociodemographic, vascular risk factor, behavioral, and antidepressive medication variables (β [95% confidence interval] = -0.21 [-0.33 to -0.10], p = 0.0003). Greater depressive symptoms were also associated with smaller cerebral parenchymal fraction (β [95% confidence interval] = -0.56 [-1.05 to -0.07], p = 0.02) and increased odds of subclinical brain infarcts (odds ratio [95% confidence interval] = 1.55 [1.00-2.42], p = 0.05), after adjustment for sociodemographic, behavioral, and vascular risk factor variables. Greater depressive symptoms were not significantly associated with white matter hyperintensity volume, hippocampal volume, or change in cognition over an average of 5 years. Results were unchanged when stabilized inverse probability weights were applied to address selective attrition during the study period. CONCLUSIONS: In this sample of mostly Caribbean Hispanic, stroke-free, older adults, greater depressive symptoms were associated with worse episodic memory, smaller cerebral volume, and silent infarcts.

AB - OBJECTIVE: We examined whether greater depressive symptoms were associated with domain-specific cognitive performance, change in cognition, and MRI markers of brain atrophy and subclinical cerebrovascular disease in a diverse sample of older adults from the Northern Manhattan Study. METHODS: Data were analyzed from the Northern Manhattan Study, a prospective cohort study of mostly Caribbean Hispanic, stroke-free, older adults. A total of 1,111 participants had baseline measures of depressive symptoms, measured as the Center of Epidemiological Studies-Depression Scale, MRI markers, and cognitive function. A Center of Epidemiological Studies-Depression score ≥16 was considered indicative of greater depressive symptoms. Multivariable linear and logistic regression models were used to examine the associations of interest. RESULTS: At baseline, 22% of participants had greater depressive symptoms. Greater depressive symptoms were significantly associated with worse baseline episodic memory in models adjusted for sociodemographic, vascular risk factor, behavioral, and antidepressive medication variables (β [95% confidence interval] = -0.21 [-0.33 to -0.10], p = 0.0003). Greater depressive symptoms were also associated with smaller cerebral parenchymal fraction (β [95% confidence interval] = -0.56 [-1.05 to -0.07], p = 0.02) and increased odds of subclinical brain infarcts (odds ratio [95% confidence interval] = 1.55 [1.00-2.42], p = 0.05), after adjustment for sociodemographic, behavioral, and vascular risk factor variables. Greater depressive symptoms were not significantly associated with white matter hyperintensity volume, hippocampal volume, or change in cognition over an average of 5 years. Results were unchanged when stabilized inverse probability weights were applied to address selective attrition during the study period. CONCLUSIONS: In this sample of mostly Caribbean Hispanic, stroke-free, older adults, greater depressive symptoms were associated with worse episodic memory, smaller cerebral volume, and silent infarcts.

UR - http://www.scopus.com/inward/record.url?scp=85067537303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067537303&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000005639

DO - 10.1212/WNL.0000000000005639

M3 - Article

VL - 90

SP - e2077-e2085

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 23

ER -